Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

videos

Ticiana Leal, MD
Videos
The Case for Alectinib in ALK-Positive NSCLC
09/22/2023

Featuring Ticiana Leal, MD 

Featuring Ticiana Leal, MD 
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Ticiana Leal, MD, debated in favor of alectinib over lorlatinib when considering treatment options for patients with ALK-positive non-small cell lung cancer (NSCLC).
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Ticiana Leal, MD, debated in favor of alectinib over lorlatinib when considering treatment options for patients with ALK-positive non-small cell lung cancer (NSCLC).
At the Great Debates & Updates...
09/22/2023
Oncology
Daniel Gomez, MD, Memorial Sloan Kettering
Videos
The Case Against Prophylactic Cranial Irradiation for Patients With SCLC
06/15/2023
Daniel Gomez, MD, summarizes his argument against prophylactic cranial irradiation for patients with small-cell lung cancer, a stance he defended in a debate session at the Great Debates and Updates in Lung Cancer conference in Chicago,...
Daniel Gomez, MD, summarizes his argument against prophylactic cranial irradiation for patients with small-cell lung cancer, a stance he defended in a debate session at the Great Debates and Updates in Lung Cancer conference in Chicago,...
Daniel Gomez, MD, summarizes his...
06/15/2023
Oncology
Corey Langer, MD, Abramson Cancer Center
Videos
How to Handle Elderly Patients and Individuals With Performance Status 2 and NSCLC
06/14/2023
At the 2023 Great Debates and Updates in Lung Cancer in Chicago, Illinois, Corey Langer, MD, Abramson Cancer Center, University of Pennsylvania, discussed how to best care for the elderly patient population, as well and patients with...
At the 2023 Great Debates and Updates in Lung Cancer in Chicago, Illinois, Corey Langer, MD, Abramson Cancer Center, University of Pennsylvania, discussed how to best care for the elderly patient population, as well and patients with...
At the 2023 Great Debates and...
06/14/2023
Oncology
Rebecca Heist, MD, Massachusetts General Hospital, Boston, MA
Videos
Updates in the Treatment of Patients With Small Cell Lung Cancer
05/18/2023
At the 2023 Great Debates and Updates Conference in Chicago, Illinois, Rebecca Heist, MD, discusses developments and advances in the treatment of small cell lung cancer.
At the 2023 Great Debates and Updates Conference in Chicago, Illinois, Rebecca Heist, MD, discusses developments and advances in the treatment of small cell lung cancer.
At the 2023 Great Debates and...
05/18/2023
Oncology
Edward Garon, MD, University of California, Los Angeles
Videos
Immuno-Oncology Alone for Patients With Lung Cancer and High PD-L1 Expression
05/18/2023
At the Great Debates and Updates in Lung Cancer conference in Chicago, Illinois, Eddie Garon, MD, makes the case for immuno-oncology alone as the optimal course of treatment lung cancer with PD-L1 expression ≥50%.
At the Great Debates and Updates in Lung Cancer conference in Chicago, Illinois, Eddie Garon, MD, makes the case for immuno-oncology alone as the optimal course of treatment lung cancer with PD-L1 expression ≥50%.
At the Great Debates and Updates...
05/18/2023
Oncology
Patrick Forde, MD, Johns Hopkins Medical Institute, Baltimore, MD
Videos
Chemotherapy Plus Immuno-Oncology for Lung Cancer With High PD-L1 Expression
05/18/2023
At the 2023 Great Debates and Updates Conference in Chicago, Illinois, Patrick Forde, MD, makes the case for chemotherapy plus immuno-oncology as the best treatment for patients with lung cancer who have a PD-L1 expression of ≥50%.
At the 2023 Great Debates and Updates Conference in Chicago, Illinois, Patrick Forde, MD, makes the case for chemotherapy plus immuno-oncology as the best treatment for patients with lung cancer who have a PD-L1 expression of ≥50%.
At the 2023 Great Debates and...
05/18/2023
Oncology
Vinai Gondi, MD, Northwestern Medicine West Region, Warrensville, IL
Videos
Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer
05/18/2023
Vinai Gondi, MD, explains his position on prophylactic cranial irradiation for patients with small-cell lung cancer, a controversy he addressed in a debate session at the Great Debates and Updates in Lung Cancer conference in Chicago,...
Vinai Gondi, MD, explains his position on prophylactic cranial irradiation for patients with small-cell lung cancer, a controversy he addressed in a debate session at the Great Debates and Updates in Lung Cancer conference in Chicago,...
Vinai Gondi, MD, explains his...
05/18/2023
Oncology
Heather Wakelee, MD, Stanford University, Palo Alto, California
Videos
Frontline Treatment Options for Patients With EGFR-Mutated NSCLC
05/18/2023
Heather Wakelee, MD, discusses first-line treatment options for patients with EGFR-mutant non-small cell lung cancer.
Heather Wakelee, MD, discusses first-line treatment options for patients with EGFR-mutant non-small cell lung cancer.
Heather Wakelee, MD, discusses...
05/18/2023
Oncology
Helena Yu, MD, Memorial Sloan Kettering Cancer Center, New York, NY
Videos
Combating Resistance to EGFR Tyrosine Kinase Inhibitors in Patients With Lung Cancer
05/17/2023
At the 2023 Great Debates and Updates Conference in Chicago, IL, Helena Yu, MD, discusses the challenges of primary and secondary resistance to EGFR tyrosine kinase inhibitors among patients with lung cancer.
At the 2023 Great Debates and Updates Conference in Chicago, IL, Helena Yu, MD, discusses the challenges of primary and secondary resistance to EGFR tyrosine kinase inhibitors among patients with lung cancer.
At the 2023 Great Debates and...
05/17/2023
Oncology
Kim Norris, Lung Cancer Foundation of America
Videos
Understanding and Employing Patient Advocacy
05/16/2023
At the 2023 Great Debates and Updates conference in Chicago Illinois, Kim Norris, co-founder and president of the Lung Cancer Foundation of America, discussed the different types of patient advocacy and the effect advocacy can have on...
At the 2023 Great Debates and Updates conference in Chicago Illinois, Kim Norris, co-founder and president of the Lung Cancer Foundation of America, discussed the different types of patient advocacy and the effect advocacy can have on...
At the 2023 Great Debates and...
05/16/2023
Oncology

Advertisement

About

Formerly known as Perspectives in Thoracic Oncology, the lung cancer meeting you know and love is getting a makeover. With an updated name to reflect a more pronounced focus on targeted therapies, biomarker testing and precision medicine, year 25 of this educational gathering is getting practical. Personalized Therapies in Thoracic Oncology will go beyond chemotherapy and focus on the best way to treat your patients when traditional methods aren't cutting it. 

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use